Provention Bio, Inc (PRVB) Stock Discussions on Social Media

Wish I could buy more. This will pass quick

$16 plus todaySec offering OverOn right track

No pain No gainBuy low sell high

Any idea on the progress of the offering? It is supposed to close today.... but there is still 1m allowed as a 30days option.... does this means we will be here for until Feb 19th?

Intravacc announces completion of formulation and manufacturing process development of PRV-101 vaccine candidate for Provention Bio”

Look for $20 plus in 2 weeks

in frnkfurt today solid red

20 is easy to get back to for this stock now cash rich & lot of news in futureBright FutureI bought IMMU same way went up significantly and was acquired in few months.Went from $20 to $ 80 in few months

I believe in the three days rule in that any news impacting the stock generally carries its effect, positive or negative, for three days. In this case, the secondary shares offering was yesterday, so the coming Tuesday will be the last day this news rendering some effect on the share price. It does look the short term bottom is $15, so I believe it may still trade near this level and after Tuesday, it should be moving gradually up with so many positive developments and catalysts in store for the company until the FDA approval date on July 1. A couple posters tried to turn this additional shares of the secondary into a big negative saying these shares would be available and sold at $13 or lower. May be they attributed their low intelligence to these new institutional and fund buyers. No one in his right mind is going to take a position without expecting to at least making 50%, if not double in a year. Yes, fund managers are not working to buy high and sell low or they won’t have the job any more. The fact they could sell 100 millions worth of new shares actually reflects high demands with shares going to stable hands. The past couple days’ drop merely reflects those unsophisticated speculators trigger happy action. Good to rid of these players.If any of you are true longs with faith in this co, you should thank for the opportunity to add more, right after it hit $20 only three days ago. Nothing has changed but better and stronger finance for the co to go forward.

Bought 4-th time. averaged down to 16.18. Now it's time to bury and forget about this stock.

While I do know small biotechs need strong financials to keep the drug development ahead of others, it sometimes is frustrating to witness your holding losing value in an instant!About six months ago, PRVB released superb data indicating its drug delayed the T1 D for a fully three years! Stock responded and shot up to then all time high of $15.5, then the co announced secondary share offering the next day and immediately killed the rally and the share price dropped big time and at one point dropped to single digit! I hang on to my shares and even picked up more. With the positive FDA response and well-accepted presentation Monday to investors, share had finally moved up to new high of $20! My glee was short-lived as the next day, same as six months ago, a secondary offering was announced and later was priced next day at $16. Share now dropped to lower than the secondary offering. Why? I believe many long time holders were very frustrated to have no time to see their investment hitting new high. Many might just take profit now. However I do understand and even have my speculation why it made such secondary offering this time. First,with the approval pretty much assured, the co is engaging in planning for marketing of the drug and in educating the medical community of such a breakthrough development which will soon be available. Then the co is embarking in two very significant endeavors; trial to see if the drug can even be used as treatment for T1 D patients, not just for delaying its onset. Another one is to develop ways to detect those carry the defective/damaged gene leading to the need for prevention. Both directions, if successfully proved, will increase the value of this stock by many times over. These trials need enormous fund to carry out.The speculation as to why it did at this time following its obviously successful presentation in the investor forum, was many institutions and fund managers might have wanted to either establish or add to their existing position, thus the need to acquire more shares without spiking up the price. In any case, selling at this time knowing in six months or less to have a drug soon to be approved with potential for 1 to 2 billions revenue is definitely the wrong move.I bought more today again and consider it’s a gift!

For those to have sold at lower than the secondary price of $16 are really dump. The $16 now serves to be the support level. Nobody bought at $16 without plan to make money on those shares and usually hoping for at least 50% higher to worth their while. I believe those shares mostly were bought by institutions. Remember the offering was right after its presentation and its price hitting all time high of $20! So fund managers and institutions liked the presentation and wanted in or add to their positions. The management would be happy to comply to also take in more money for marketing the drug plus doing the trials for the T1 diabetic patients. Now we have a co not only gets FDA approval on July 1 or earlier, but also embarking on developing treatment for existing T1 D patients. Wow, just think of the potential beyond the almost certain approval of the prevention drug. Sky is the limit for this co operating with no competition. Those who sold shares will regret in less than six months. That’s why in stock market there are always losers and winners with the latter take money from the former.

I suppose $100M+ is too much to have considered private placement or preferred shares that wouldn't have diluted the float and destroyed the PPS.. but hey, if they needed the money, they needed the money. We should have only dropped 10%. The rest is shorting and it ain't stopping anytime soon

Scooped up a bunch at 16.23. Stoked on this one.

5.9 MM volume today and high yesterday- hopefully shares bought and sellers out so we can start moving up again

it might not get to $13.50......so i bought yesterday and averaged down to $16.76 today.....should never of left.....living the dream......glta.....will add more tuesday.......

Offering at $16.00 p/s

Tim, I agree. That was a gift to add more this morning at 16.25

Anyone know for certain yet what public offering price is? Not some estimate from seat of your pants please...

Bought more today